Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase.

Yang P, Collin P, Madden T, Chan D, Sweeney-Gotsch B, McConkey D, Newman RA.

Prostate. 2003 Jun 1;55(4):281-91.

PMID:
12712407
2.

Fatty acid oxidation and signaling in apoptosis.

Tang DG, La E, Kern J, Kehrer JP.

Biol Chem. 2002 Mar-Apr;383(3-4):425-42. Review.

PMID:
12033433
3.

Lipoxygenase inhibition in prostate cancer.

Myers CE, Ghosh J.

Eur Urol. 1999;35(5-6):395-8. Review.

PMID:
10325495
4.

Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications.

Nie D, Tang K, Szekeres K, Li L, Honn KV.

Ann N Y Acad Sci. 2000 Apr;905:165-76. Review.

PMID:
10818452
5.

Role of eicosanoids in prostate cancer progression.

Nie D, Che M, Grignon D, Tang K, Honn KV.

Cancer Metastasis Rev. 2001;20(3-4):195-206. Review.

PMID:
12085962
6.

Lipoxygenase modulation to reverse carcinogenesis.

Shureiqi I, Lippman SM.

Cancer Res. 2001 Sep 1;61(17):6307-12. Review.

7.

The effect of 15-lipoxygenase-1 expression on cancer cells.

Kelavkar U, Glasgow W, Eling TE.

Curr Urol Rep. 2002 Jun;3(3):207-14. Review.

PMID:
12084190
8.

5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy.

Bishayee K, Khuda-Bukhsh AR.

Acta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):709-19. doi: 10.1093/abbs/gmt064. Epub 2013 Jun 9. Review.

PMID:
23752617
9.

[Fatty acids as a potentially helpful supplement in cancer therapy].

Przybyszewski WM, Widel M.

Postepy Hig Med Dosw. 2002;56(5):589-602. Review. Polish.

PMID:
12587427
10.

The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Bell RL, Harris RR.

Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):91-109. Review. No abstract available.

PMID:
10436861
11.

[Studies on 5-lipoxygenase inhibitors. Synthesis of and structure--activity relationship in p-hydroxyarylalkenylbenzoazoles].

Kosaka T, Ochiai K, Ohba S, Wakabayashi T, Murota S.

Yakugaku Zasshi. 1997 Sep;117(9):611-7. Review. Japanese.

PMID:
9357329
12.

Effect of 15-HETE on the 5-lipoxygenase pathway in neutrophils. Genuine inhibitor or alternative substrate?

Schewe T, Petrich K, Ludwig P, Kühn H, Nigam S.

Adv Exp Med Biol. 1999;447:95-105. Review. No abstract available.

PMID:
10086186
13.

The yin and the yang of 5-lipoxygenase pathway activation.

Bigby TD.

Mol Pharmacol. 2002 Aug;62(2):200-2. Review. No abstract available.

14.

Influence of short chain fatty acids on the epithelial cell division of digestive tract.

Sakata T, Yajima T.

Q J Exp Physiol. 1984 Jul;69(3):639-48. Review. No abstract available.

15.

Anaplerotic reactions in tumour proliferation and apoptosis.

Quash G, Fournet G, Reichert U.

Biochem Pharmacol. 2003 Aug 1;66(3):365-70. Review.

PMID:
12907234

Supplemental Content

Support Center